WEST PHARMACEUTICAL SVSC INC shareholders Q3 2023

WEST PHARMACEUTICAL SVSC INC's ticker is WST and the CUSIP is 955306105. A total of 742 filers reported holding WEST PHARMACEUTICAL SVSC INC in Q3 2023. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

WEST PHARMACEUTICAL SVSC INC shareholders Q3 2023
NameSharesValueWeighting ↓
Conestoga Capital Advisors, LLC 56,393$21,159,2180.36%
Rhenman & Partners Asset Management AB 9,000$3,376,8900.36%
Kensington Investment Counsel, LLC 1,563$586,4530.36%
Monte Financial Group, LLC 1,896$711,4470.36%
Virtus Investment Advisers, Inc. 1,383$518,9150.35%
USA FINANCIAL FORMULAS 629$236,0070.35%
Heritage Investment Group, Inc. 3,371$1,265,0000.35%
Revisor Wealth Management LLC 1,046$392,4700.33%
NORDEN GROUP LLC 2,626$985,2480.32%
Lloyd Advisory Services, LLC. 2,626$985,2480.32%
Evergreen Wealth Solutions, LLC 795$298,2920.30%
Epoch Investment Partners, Inc. 124,392$46,673,1230.30%
First Affirmative Financial Network 801$300,5260.29%
Congress Wealth Management LLC / DE / 37,430$14,044,6380.29%
KINGSWOOD WEALTH ADVISORS, LLC 4,496$1,686,9440.29%
Wallace Advisory Group, LLC 1,033$395,0920.28%
Man Group plc 243,925$91,523,0990.28%
Bank of New York Mellon Corp 3,389,320$1,271,706,6650.28%
CIM INVESTMENT MANAGEMENT INC 2,012$754,9230.28%
MACQUARIE GROUP LTD 580,781$217,914,5880.27%
About WEST PHARMACEUTICAL SVSC INC

West Pharmaceutical Services, Inc. is a global leader in innovative solutions for injectable drug administration. The company has been in business for over 100 years and has a strong reputation for quality and reliability. West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania, and has operations in North and South America, Europe, Asia, and Australia.

West Pharmaceutical Services, Inc. has a diverse portfolio of products and services that cater to the needs of the pharmaceutical and biotech industries. The company's products include stoppers and seals for vials, syringe and cartridge components, and drug delivery systems. West Pharmaceutical Services, Inc. also offers analytical and testing services, as well as contract manufacturing services.

The company's success can be attributed to its commitment to innovation and customer satisfaction. West Pharmaceutical Services, Inc. invests heavily in research and development to create new products and improve existing ones. The company also works closely with its customers to understand their needs and provide customized solutions.

West Pharmaceutical Services, Inc. has a strong financial position, with a market capitalization of over $20 billion. The company's revenue has been steadily increasing over the past few years, and it has a solid balance sheet with low debt levels.

In conclusion, West Pharmaceutical Services, Inc. is a well-established and reputable company that provides innovative solutions for injectable drug administration. The company's commitment to innovation and customer satisfaction has helped it maintain its position as a global leader in the industry. With a strong financial position and a diverse portfolio of products and services, West Pharmaceutical Services, Inc. is well-positioned for continued success in the future.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists WEST PHARMACEUTICAL SVSC INC's shareholders in Q3 2023. To view WEST PHARMACEUTICAL SVSC INC's shareholder history, click here.